Loading...
Products:Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> Other
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-PADPR antibody [10H]
See all PADPR products (2) ...
Mouse monoclonal [10H] to PADPR
This antibody reacts with PADPR synthesized by a variety of poly(ADP- ribose) polymerases (PARP)-related enzymes including PARP1, 2, 3, tankyrase, vPARP, sPARP and others. The antibody does not cross-react with ADP-ribose, 5'-AMP, or yeast RNA as tested by ELISA.
WB, ELISA, ICC/IF, IHC-Frmore details
Reacts with
Rat, Human
PADPR mixed with methylated bovine serum albumin.
Rat liver induced for PADPR synthesis by injection with diethylnitrosamine.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, 20mM Tris, 150mM Sodium Chloride. pH 7.4
Concentration information loading...
Protein A purified
Monoclonal
10H
NS1
IgG3
kappa
Signal Transduction >> Second Messenger >> Nucleotide Messenger >> cAMP
Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> Other
Our Abpromise guarantee covers the use of ab14459 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 2 - 10 µg/ml. 2 µg/ml, if using ECL or 10 µg/ml, if using colorimetric methods.
ELISA: Use at an assay dependent dilution.
ICC/IF: 1/400.
IHC-Fr: Use at an assay dependent dilution.
PADPR (Poly(ADP-ribose)) is a polymer synthesized by a class of enzymes named poly(ADP-ribose) polymerases (PARP). Using NAD+ as substrate, PARP catalyzes the formation of the polymer PADPR, with chain lengths ranging from 2 to 300 residues, containing approximately 2% branching in the chain. PADPR becomes attached to nuclear proteins, and to PARP itself (automodification). Under normal conditions, cells display low basal level of PADPR polymer, which can dramatically increase in cells exposed to DNA damaging agents (irradiation, alkylation, etc.). This increase of polymer synthesis is usually transient and is followed by a rapid degradation phase with a short half life which can be less than 1 min. The low endogenous level of polymer in unstimulated cells and its rapid catabolism during DNA damage has been ascribed to high activity of the polymer catabolizing enzyme poly(ADP-ribose) glycohydrolyase (PARG).
Immunohistochemistry (Frozen sections) - PADPR antibody [10H] (ab14459)
![Immunohistochemistry (Frozen sections) - PADPR antibody [10H] (ab14459)](/ps/datasheet/images/14/ab14459/PADPR-Primary-antibodies-ab14459-1.jpg)
Immunohistochemistry of rat livers treated with diethylnitrosamine (200 mg/kg) and stained with ab14459 diluted 1/100. After treatment livers were removed and rapidly processed 10 hr later, at peak polymer induction. Left hand side image was from diethylnitrosamine untreated liver tissue and right one represents DEN treated sections.
Immunocytochemistry/ Immunofluorescence - PADPR antibody [10H] (ab14459)
![Immunocytochemistry/ Immunofluorescence - PADPR antibody [10H] (ab14459)](/ps/datasheet/images/14/ab14459/PADPR-Primary-antibodies-ab14459-6.jpg)
ab14459 staining PADPR in human breast cancer cells (MCF7 cells) by Immunocytochemistry/ Immunofluorescence. The cells were paraformaldehyde fixed, permeabilised in 0.2% Triton/ PBS and then blocked using 1% BSA and 3% FBS in PBS for 30 minutes at room temperature. Samples were then incubated with primary antibody at 1/50 for 1 hour. The secondary antibody used was a goat anti-mouse IgG conjugated to Alexa Fluor® 555 (red) used at a 1/500 dilution.
Image courtesy of Dr Manikandan Periyasamy by Abreview.
Western blot - Anti-PADPR antibody [10H] (ab14459)
![Western blot - Anti-PADPR antibody [10H] (ab14459)](/ps/datasheet/images/14/ab14459/PADPR-Primary-antibodies-ab14459-11.jpg)
All lanes : Anti-PADPR antibody [10H] (ab14459) at 1/1000 dilution
Lane 1 : Ladder
Lane 2 : Ladder
Lane 3 : Whole cell lysate prepared from MEF's
Lane 4 : Whole cell lysate prepared from MEF's treated with 500um Hydrogen Peroxide, 10 minutes
Lane 5 : Whole cell lysate prepared from MEF's treated with 500um Hydrogen Peroxide, 20 minutes
Lane 6 : Whole cell lysate prepared from MEF's treated with 500um Hydrogen Peroxide, 30 minutes
Secondary
IRDye 800CW conjugated goat monoclonal at 1/10000 dilution
Image courtesy of Dr Aashish Joshi by Abreview.
This product has been referenced in:
See all 3 publications for this product
Publishing research using ab14459? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunohistochemistry (Frozen sections) - PADPR antibody [10H] (ab14459)](/ps/datasheet/images/14/ab14459/PADPR-Primary-antibodies-ab14459-1.jpg)
Immunohistochemistry of rat livers treated with diethylnitrosamine (200 mg/kg) and stained with ab14459 diluted 1/100. After treatment livers were removed and rapidly processed 10 hr later, at peak polymer induction. Left hand side image was from diethylnitrosamine untreated liver tissue and right one represents DEN treated sections.
![Immunocytochemistry/ Immunofluorescence - PADPR antibody [10H] (ab14459)](/ps/datasheet/images/14/ab14459/PADPR-Primary-antibodies-ab14459-6.jpg)
ab14459 staining PADPR in human breast cancer cells (MCF7 cells) by Immunocytochemistry/ Immunofluorescence. The cells were paraformaldehyde fixed, permeabilised in 0.2% Triton/ PBS and then blocked using 1% BSA and 3% FBS in PBS for 30 minutes at room temperature. Samples were then incubated with primary antibody at 1/50 for 1 hour. The secondary antibody used was a goat anti-mouse IgG conjugated to Alexa Fluor® 555 (red) used at a 1/500 dilution.
Image courtesy of Dr Manikandan Periyasamy by Abreview.
2
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
